About Ritsa Pharma Private Limited
Data last updated:
Ritsa Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC145093. Its GSTIN is 36AAKCR5379J1ZP (Telangana).
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹31.58 Cr. It is led by directors including Chandrasekhar Penugonda and Ganji Kishore Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8.28 Cr (net margin -91.8%) and EBITDA of -₹7.22 Cr (EBITDA margin -80.1%).
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.52 Cr on record. Court records list 1 case involving the company. The company has 1 deal on record (1 rights issue); the latest was in June 2021. Its 10 peer companies in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Thexa Pharma Private Limited with revenue of ₹9.03 Cr.
For more details, the company can be reached via its website ritsapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address3600 Plot No. 4 Survey Nos. 101 101/2 & 340, Lalgadi Malakpet (Village) Genome Valley, Hyderabad, Telangana, India – 500101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ritsa Pharma Private Limited
The main business activity of Ritsa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ritsa Pharma Private Limited FY 2025 filings available
Ritsa Pharma Private Limited reported revenue of ₹9.01 Cr (up 273% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ritsa Pharma Private Limited
Revenue rose 273% in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ritsa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.28 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ritsa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -80.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -91.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ritsa Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ritsa Pharma Private Limited
Ritsa Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thexa Pharma Private Limited | ₹9.03 Cr (FY 2018) | •••• | •••• | -84.0% | •••• | Madgul, Telangana, India |
| SKD Pharma Products Private Limited | ₹9.02 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Greenmint India Agritech Private Limited | ₹9.02 Cr (FY 2024) | •••• | •••• | 64.0% | •••• | Hyderabad, Telangana, India |
| Cheran Beauty Care Products Private Limited | ₹9.02 Cr (FY 2023) | •••• | •••• | -36.0% | •••• | Coimbatore, Tamil Nadu, India |
| Agri Biochem Private Limited | ₹9.02 Cr (FY 2025) | •••• | •••• | 245.0% | •••• | Kolkata, West Bengal, India |
| Ritsa Pharma Private Limited this company | ₹9.01 Cr (FY 2025) | •••• | •••• | 273.0% | •••• | Hyderabad, Telangana, India |
| Bharwada Healthcare Private Limited | ₹9.01 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Areva Paints Private Limited | ₹9 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Kora Hobli, Karnataka, India |
| Medisum Biotech Private Limited | ₹9 Cr (FY 2024) | •••• | •••• | 449.0% | •••• | Delhi, India |
| Kamani Chemicals Private Limited | ₹9 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Jamuria, West Bengal, India |
| Amsar Goa Private Limited | ₹9 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Goa, India |
Peers are the five companies nearest above and the five nearest below Ritsa Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ritsa Pharma Private Limited
Ritsa Pharma Private Limited is audited by KALYANA AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KALYANA AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ritsa Pharma Private Limited
Ritsa Pharma has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrasekhar Penugonda Also directs: Tinitiate Technologies Private Limited | Director | 10 Apr 2024 | 2 Years 6 Months | Current |
| Ganji Kishore Kumar Also directs: Isv Management Consultancy LLP, Earthbound Organic Farms Private Limited, Smart Agro Food Park Private Limited and 5 more | Director | 21 Oct 2020 | 5 Years 11 Months | Current |
| Narendra Babu Vutla Also directs: Vivaan Assisted Living Private Limited | Director | 07 Jul 2023 | 3 Years 3 Months | Current |
| Srilalitha Bhattaram | Director | 24 Feb 2021 | 5 Years 7 Months | Current |
| Manaswini Vemulapalli Also directs: Sereno Life Sciences Private Limited | Nominee Director | 09 Aug 2021 | 5 Years 2 Months | Current |
| Venkateswara Rao Yarlagadda | Director | 21 Oct 2021 | 4 Years 11 Months | Current |
Ownership and Shareholding of Ritsa Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ritsa Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | State Bank of India | ₹4.52 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Ritsa Pharma Private Limited
Ritsa Pharma Private Limited has 1 deal on record (1 rights issue); the latest was in June 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Rights issue | ₹3.02 Cr | Investors: Sereno Life Sciences Private Limited , 3 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Ritsa Pharma Private Limited
Ritsa Pharma Private Limited has 1 court case on record: 1 where it is another party. All case is disposed. Status as checked on 28 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Court case (CRLP) | Company is another party | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Ritsa Pharma Private Limited
Employment history and EPFO contributions of people linked to Ritsa Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ritsa Pharma Private Limited
Ritsa Pharma Private Limited has 12 board changes on record since 2020: 7 appointments and 5 cessations. The latest: Venkata Subramanya Ravi Kumar Gannavarapu was appointed as Company Secretary on 01 Jul 2025.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ritsa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ritsa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ritsa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ritsa Pharma Private Limited
Ritsa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCR5379J1ZP | Telangana | Active | 31 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ritsa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ritsa Pharma Private Limited
Ritsa Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 October 2020 (6+ years old) and is registered under CIN U24290TG2020PTC145093.
Ritsa Pharma reported revenue of ₹9.01 Cr for FY 2025 (up 273% YoY).
Ritsa Pharma has 6 current directors:
- Chandrasekhar Penugonda - Director
- Ganji Kishore Kumar - Director
- Narendra Babu Vutla - Director
- Srilalitha Bhattaram - Director
- Manaswini Vemulapalli - Nominee Director
- Venkateswara Rao Yarlagadda - Director
Ritsa Pharma reported a net loss of ₹8.28 Cr (net margin -91.8%) and EBITDA of -₹7.22 Cr (EBITDA margin -80.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Ritsa Pharma is 36AAKCR5379J1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Ritsa Pharma is U24290TG2020PTC145093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ritsa Pharma has 1 court case on record.
Ritsa Pharma was incorporated on 21 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ritsa Pharma has 1 deal on record (1 rights issue); the latest was in June 2021.
The peers of Ritsa Pharma by revenue are Thexa Pharma Private Limited, SKD Pharma Products Private Limited, Greenmint India Agritech Private Limited, Cheran Beauty Care Products Private Limited, Agri Biochem Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Venkata Subramanya Ravi Kumar Gannavarapu was appointed as Company Secretary on 01 Jul 2025. Chandrasekhar Penugonda ceased to be Additional Director on 09 May 2024. Chandrasekhar Penugonda was appointed as Director on 10 Apr 2024. Ritsa Pharma has 12 board changes on record in total.